ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "df259437-5335-4f58-8953-49029210f080"}, "_deposit": {"created_by": 17, "id": "2006263", "owners": [17], "pid": {"revision_id": 0, "type": "depid", "value": "2006263"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:02006263", "sets": ["1685060434835"]}, "author_link": [], "control_number": "2006263", "item_1615768549627": {"attribute_name": "出版タイプ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_9_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2023-05", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "254", "bibliographicPageStart": "241", "bibliographicVolumeNumber": "85", "bibliographic_titles": [{"bibliographic_title": "Nagoya Journal of Medical Science", "bibliographic_titleLang": "en"}]}]}, "item_9_description_4": {"attribute_name": "内容記述", "attribute_value_mlt": [{"subitem_description": "The local control rates of T1 bulky and T2 glottic carcinoma treated via radiation therapy alone are unsatisfactory; thus, we aimed to evaluate the efficacy and safety of our treatment protocol for early glottic carcinoma. Patients with early glottic squamous cell carcinoma treated via radiation therapy from January 2007 to November 2019 were reviewed. Patients were treated with: 63–67.5 Gy/28–30 fractions of radiation therapy alone for T1 non-bulky; concurrent chemoradiotherapy with S-1 and 60 Gy/30 fractions for T1 bulky and T2 favorable; and concurrent chemoradiotherapy with high-dose cisplatin and 66–70 Gy/33–35 fractions for T2 unfavorable glottic carcinoma. Local failure rates were estimated using the cumulative incidence function, overall and disease specific survival rates were estimated using Kaplan-Meier analysis, and adverse events were evaluated. Eighty patients were analyzed; the median age was 69.5 (range, 26–90) years, the median follow-up time for survivors was 40.1 (range, 1.9–128.4) months, and the 3-year local failure, disease specific survival, and overall survival rates were 5.8%, 98.3%, and 94.4%, respectively. In T1 bulky and T2 cases, the local failure rate was significantly lower in the concurrent chemoradiotherapy than in the radiation therapy alone group. Grade 3 acute dermatitis and mucositis were noted in nine and four patients, respectively. There were no acute adverse events of Grade 4 or higher, or late adverse events of Grade 2 or higher. The treatment protocol was effective and well-tolerated; thus, the efficacy of concurrent chemoradiotherapy was suggested in T1 bulky and T2 cases.", "subitem_description_language": "en", "subitem_description_type": "Abstract"}, {"subitem_description": "This is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).", "subitem_description_language": "en", "subitem_description_type": "Other"}]}, "item_9_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.18999/nagjms.85.2.241", "subitem_identifier_reg_type": "JaLC"}]}, "item_9_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Nagoya University Graduate School of Medicine, School of Medicine", "subitem_publisher_language": "en"}]}, "item_9_relation_43": {"attribute_name": "関連情報", "attribute_value_mlt": [{"subitem_relation_type": "isVersionOf", "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/852.html", "subitem_relation_type_select": "URI"}}]}, "item_9_rights_12": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International", "subitem_rights_language": "en", "subitem_rights_resource": "http://creativecommons.org/licenses/by-nc-nd/4.0/"}]}, "item_9_source_id_7": {"attribute_name": "収録物識別子", "attribute_value_mlt": [{"subitem_source_identifier": "0027-7622", "subitem_source_identifier_type": "PISSN"}, {"subitem_source_identifier": "2186-3326", "subitem_source_identifier_type": "EISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "open access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_abf2"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Ono, Tamami", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Itoh, Yoshiyuki", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Ishihara, Shunichi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Kawamura, Mariko", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Oie, Yumi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Takase, Yuuki", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Okumura, Masayuki", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Oyoshi, Hidekazu", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Nagai, Naoya", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Naganawa, Shinji", "creatorNameLang": "en"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_access", "date": [{"dateType": "Available", "dateValue": "2023-05-26"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "04_Ono.pdf", "filesize": [{"value": "900 KB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_5", "mimetype": "application/pdf", "size": 900000.0, "url": {"objectType": "fulltext", "url": "https://nagoya.repo.nii.ac.jp/record/2006263/files/04_Ono.pdf"}, "version_id": "3abcea8f-6a6b-48d0-bd37-e5785538c623"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "early glottic carcinoma", "subitem_subject_scheme": "Other"}, {"subitem_subject": "radiation therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "chemoradiotherapy", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Optimized radiotherapy treatment strategy for early glottic carcinoma", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Optimized radiotherapy treatment strategy for early glottic carcinoma", "subitem_title_language": "en"}]}, "item_type_id": "40001", "owner": "17", "path": ["1685060434835"], "permalink_uri": "https://doi.org/10.18999/nagjms.85.2.241", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2023-05-26"}, "publish_date": "2023-05-26", "publish_status": "0", "recid": "2006263", "relation": {}, "relation_version_is_last": true, "title": ["Optimized radiotherapy treatment strategy for early glottic carcinoma"], "weko_shared_id": -1}
  1. C100 医学部/医学系研究科
  2. C100b 紀要
  3. Nagoya journal of medical science
  4. 85(2)

Optimized radiotherapy treatment strategy for early glottic carcinoma

https://doi.org/10.18999/nagjms.85.2.241
https://doi.org/10.18999/nagjms.85.2.241
af18d02e-4888-4ed4-a43d-560d09ac8779
名前 / ファイル ライセンス アクション
04_Ono.pdf 04_Ono.pdf (900 KB)
license.icon
Item type itemtype_ver1(1)
公開日 2023-05-26
タイトル
タイトル Optimized radiotherapy treatment strategy for early glottic carcinoma
言語 en
著者 Ono, Tamami

× Ono, Tamami

en Ono, Tamami

Search repository
Itoh, Yoshiyuki

× Itoh, Yoshiyuki

en Itoh, Yoshiyuki

Search repository
Ishihara, Shunichi

× Ishihara, Shunichi

en Ishihara, Shunichi

Search repository
Kawamura, Mariko

× Kawamura, Mariko

en Kawamura, Mariko

Search repository
Oie, Yumi

× Oie, Yumi

en Oie, Yumi

Search repository
Takase, Yuuki

× Takase, Yuuki

en Takase, Yuuki

Search repository
Okumura, Masayuki

× Okumura, Masayuki

en Okumura, Masayuki

Search repository
Oyoshi, Hidekazu

× Oyoshi, Hidekazu

en Oyoshi, Hidekazu

Search repository
Nagai, Naoya

× Nagai, Naoya

en Nagai, Naoya

Search repository
Naganawa, Shinji

× Naganawa, Shinji

en Naganawa, Shinji

Search repository
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
権利
言語 en
権利情報Resource http://creativecommons.org/licenses/by-nc-nd/4.0/
権利情報 Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
キーワード
主題Scheme Other
主題 early glottic carcinoma
キーワード
主題Scheme Other
主題 radiation therapy
キーワード
主題Scheme Other
主題 chemoradiotherapy
内容記述
内容記述 The local control rates of T1 bulky and T2 glottic carcinoma treated via radiation therapy alone are unsatisfactory; thus, we aimed to evaluate the efficacy and safety of our treatment protocol for early glottic carcinoma. Patients with early glottic squamous cell carcinoma treated via radiation therapy from January 2007 to November 2019 were reviewed. Patients were treated with: 63–67.5 Gy/28–30 fractions of radiation therapy alone for T1 non-bulky; concurrent chemoradiotherapy with S-1 and 60 Gy/30 fractions for T1 bulky and T2 favorable; and concurrent chemoradiotherapy with high-dose cisplatin and 66–70 Gy/33–35 fractions for T2 unfavorable glottic carcinoma. Local failure rates were estimated using the cumulative incidence function, overall and disease specific survival rates were estimated using Kaplan-Meier analysis, and adverse events were evaluated. Eighty patients were analyzed; the median age was 69.5 (range, 26–90) years, the median follow-up time for survivors was 40.1 (range, 1.9–128.4) months, and the 3-year local failure, disease specific survival, and overall survival rates were 5.8%, 98.3%, and 94.4%, respectively. In T1 bulky and T2 cases, the local failure rate was significantly lower in the concurrent chemoradiotherapy than in the radiation therapy alone group. Grade 3 acute dermatitis and mucositis were noted in nine and four patients, respectively. There were no acute adverse events of Grade 4 or higher, or late adverse events of Grade 2 or higher. The treatment protocol was effective and well-tolerated; thus, the efficacy of concurrent chemoradiotherapy was suggested in T1 bulky and T2 cases.
言語 en
内容記述タイプ Abstract
内容記述
内容記述 This is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).
言語 en
内容記述タイプ Other
出版者
言語 en
出版者 Nagoya University Graduate School of Medicine, School of Medicine
言語
言語 eng
資源タイプ
資源タイプresource http://purl.org/coar/resource_type/c_6501
タイプ departmental bulletin paper
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
ID登録
ID登録 10.18999/nagjms.85.2.241
ID登録タイプ JaLC
関連情報
関連タイプ isVersionOf
識別子タイプ URI
関連識別子 https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/852.html
収録物識別子
収録物識別子タイプ PISSN
収録物識別子 0027-7622
収録物識別子
収録物識別子タイプ EISSN
収録物識別子 2186-3326
書誌情報 en : Nagoya Journal of Medical Science

巻 85, 号 2, p. 241-254, 発行日 2023-05
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-26 01:05:03.641787
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3